BP
PGNY icon

Ballentine Partners’s Progyny PGNY Stock Holding History

Ballentine Partners’s Portfolio PGNY Stock Details PGNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$346K Sell
11,997
-501
-4% -$11.2K ﹤0.01% 721
2026
Q1 		$212K Buy
12,498
+167
+1% +$3.58K ﹤0.01% 913
2025
Q4 		$317K Buy
12,331
+912
+8% +$21K ﹤0.01% 699
2025
Q3 		$246K Buy
11,419
+48
+0.4% +$1.09K ﹤0.01% 820
2025
Q2 		$250K Buy
11,371
+203
+2% +$4.45K ﹤0.01% 776
2025
Q1 		$249K Buy
11,168
+339
+3% +$7.3K ﹤0.01% 696
2024
Q4 		$187K Buy
+10,829
New +$168K ﹤0.01% 795

Other funds holding PGNY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ballentine Partners's PGNY Position: Q2 2026 in Review

Ballentine Partners reduced its Progyny (PGNY) stake by 4% in Q2 2026, selling an estimated $11.2K and leaving 11,997 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #721.

Ballentine Partners first reported a position in PGNY in Q4 2024 and has held it in 7 quarters since. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • Ballentine Partners held 11,997 shares of Progyny worth $346K as of Q2 2026.
  • Ballentine Partners sold 501 Progyny shares in Q2 2026, an estimated $11.2K.
  • Progyny made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #721 holding.
  • Ballentine Partners first reported a position in Progyny in Q4 2024 and has held it in 7 quarters since.
  • 311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.